Botanical species · safety record

Echinops ritro

The EFSA Compendium of Botanicals holds 14 constituent measurements for Echinops ritro. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Echinops ritro L.

14Constituent measurements

0Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Thiophene	Roots and other underground parts	Solvent extraction	—	GC-MS	Resolve DOI
Thiophene	Live plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
1,8-cineole	Aerial part of plants	Essential oil	16.3 Percent	GC-MS	No resolvable identifier
2-hexenal	Aerial part of plants	Essential oil	21.4 Percent	GC-MS	No resolvable identifier
2-pentylfuran	Aerial part of plants	Essential oil	3.5 Percent	GC-MS	No resolvable identifier
Alkaloids	Fruit unspecified	—	≤ 2.2 Percent	—	No resolvable identifier
Alkaloids	Fruit unspecified	—	≥ 1.8 Percent	—	No resolvable identifier
Alpha-thujone	Aerial part of plants	Essential oil	3.2 Percent	GC-MS	No resolvable identifier
Beta-thujone	Aerial part of plants	Essential oil	1.6 Percent	GC-MS	No resolvable identifier
Camphor	Aerial part of plants	Essential oil	2.6 Percent	GC-MS	No resolvable identifier
Menthone	Aerial part of plants	Essential oil	1.5 Percent	GC-MS	No resolvable identifier
Octanal	Aerial part of plants	Essential oil	2.6 Percent	GC-MS	No resolvable identifier
Quinoline alkaloids	Live plants	—	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Sesquiterpene lactones	Live plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Papadopoulou, P., Couladis, M., Tzakou, O. Essential oil composition of two Greek Echinops species: Echinops graecus Miller and Echinops ritro L. . Journal of essential oil research, 2006, vol. 18, no. 3, p. 242-243.
Pham Thanh Ky., Schroeder, Peter. Studies on the physiology of the quinoline alkaloids in Echinops spec.. Biochemie und physiologie der pflanzen, 1976, vol. 169, no. 5, p. 461-70.
LAM, J., CHRISTENSEN, LP., THOMASEN, T. THIOPHENE DERIVATIVES FROM ECHINOPS SPECIES. Phytochemistry, 1991, vol. 30, no. 4, p. 1157-1159. DOI
SCHRODER, P., LUCKNER, M. PHYSIOLOGY OF FORMATION OF QUINOLINE ALKALOID ECHINORINE IN ECHINOPS RITRO L . Planta medica, 1968, vol. 16, no. 1, p. 99-&.
Fokialakis, Nikolas., Osbrink, Weste L. A., Mamonov, Leonid K., Gemejieva, Nadejda G., Mims, Amelia B., Skaltsounis, Alexios L., Lax, Alan R., Cantrell, Charles L. Antifeedant and toxicity effects of thiophenes from four Elchinops species against the Formosan subterranean termite, Coptotermes formosanus . Pest management science, 2006, vol. 62, no. 9, p. 832-838. DOI
Li, Liang-Bo., Ren, Jie., Cheng, Zheng-Ming., Zhu, Hua-Jie. Three New Sesquiterpenoids from Echinops ritro L.. Helvetica chimica acta, 2010, vol. 93, no. 7, p. 1344-1349.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature